Peptide of the Week: The Godfather of Peptides With Trevor Kruder
Streams straight from the publisher. podnod never proxies or re-hosts episode audio.
Medical Disclaimer: We are not doctors. The content in this video is for educational and informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Any compounds discussed may be intended for research purposes only. Use at your own risk.
Welcome back, warriors! In this episode of Peptide of the Week, JD Denham and William T. Haas sit down with Trevor Kruder the man they call the Godfather of Peptides. 12 years in the industry before most people knew what a peptide was, Trevor has built one of the most comprehensive peptide and hormone companies in the world. This one is packed.
Chapters
00:00 – Intro, Travel Plans & Life Updates
06:29 – Hormones vs. Peptides: Where to Start
13:30 – How Trevor Built a Peptide Empire
18:18 – Hiring Great People & Building Teams
22:23 – Is It Too Late to Start a Peptide Business?
31:36 – Leadership, Growth & Managing Success
37:28 – Social Media, Misinformation & Peptides
41:05 – Why China Dominates the Peptide Industry
46:22 – The Reality of Starting a Peptide Company Today
50:52 – Educating Doctors & Growing the Industry
53:08 – The Future of Peptides & Telehealth
57:20 – Final Thoughts & Closing Advice
We cover:
🏗️ How it all started
– Started synthesizing peptides from scratch 12 years ago with $30,000 and a small lab
– Spent 7 years building with almost no market nobody knew what peptides were
– Built a 20,000 doctor network and scaled to $170–180M in under 2 years
– Now operates 44+ companies including telehealth, pharmacies, drug manufacturing, research, cosmetics, hair restoration, and more
– 500–800 employees across multiple sites
🏥 What he's built
– Three telehealth companies and three 503A pharmacies
– 50-state hormone license supplies Walgreens, CVS, and rare disease medications to every major university in the US
– Two 503B sterile injectable facilities (two more being built)
– Research manufacturing sites running 12–14 IRBs and INDs per year
– AlphaSync described as Amazon for doctors, full platform for ordering peptides and hormones at a fraction of market cost
– New brick-and-mortar wellness center opening: IV, hyperbaric, red light, full gym, laser treatments all under a membership model
🔬 What's coming — peptides to watch
– FLGR-242 (Follistatin 242): modified follistatin that actually adds muscle one of the most exciting muscle builders emerging
– Lepto: GLP + GIP + Glucagon + IGF-1 once every two weeks injection, helps with weight loss while protecting muscle from wasting
– Albumin-bound semaglutide: 1/10th the normal dose with the same result no receptor burnout
– Oral peptide delivery system: coats peptide to survive digestion, bypasses liver, enters lymphatic system 24x more bioavailable in models. Human trials starting in 30 days
🌏 The peptide industry reality
– China makes 80% of the world's peptide raw materials and that's not changing their facilities cost $300M–$1B+
– Finished goods manufacturing in China is technically not legal enforcement is ramping up as China wants revenue
– American API manufacturing is nearly impossible due to environmental regulations and cost
– Anyone entering the industry now needs real money, real testing, and real infrastructure — the easy days are over
– Janoshik-style third party testing is now essential fake, empty, and underdosed vials are flooding the market
📺 Subscribe for more no-fluff peptide education every week.
Follow us on social media:
JD's Instagram: https://www.instagram.com/jddenhamofficial/
Will's Instagram: https://www.instagram.com/williamthaas/
Follow Trevor Kruder:
Website: https://alphabiomedlabs.com
Website: https://www.trevorkruder.com
Instagram: https://www.instagram.com/trevorkruder
Join The Community: https://www.skool.com/peptideresearchinstitute/about
No links were found in this episode’s notes.